CareTalk: Healthcare. Unfiltered. · 2026-04-24 · 31 min
Send us Fan Mail For decades, Parkinson's patients have been offered only symptom management. No drug has ever slowed the disease itself. A small clinical stage biotech may be about to change that. Gene Mack, CEO, Gain Therapeutics joins host David E. Williams to discuss the science behind a potential first disease modifying therapy for Parkinson's, how AI is accelerating drug discovery, and what it takes to build a biotech in one of the toughest capital markets in years. ️️ABOUT GENE MACK Gene Mack serves as Chief Executive Officer and President of Gain Therapeutics. He joined the Company in April 2024 and brings 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023. Previous to Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of Merck & Co’s (MSD) $475 million acquisition of OncoImmune in 2020 where he had also been CFO.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Michelle Gill: AI-Assisted Drug Discovery, NVIDIA, Biofoundation Models, Creating Applied Research Teams | Learning from Machine Learning #8Learning from Machine Learning · on Drug Discovery88 / 100
Success Leaves Clues: Ep 296 How Healthcare Innovation Improves Patient Access with John Leombruno, CEO at OkRx Success Leaves Clues with Robin Bailey and Al McDonald · on healthcare podcast79 / 100
Ep 216, Failure Is A Component Of SuccessConflict Managed · on neuroscience69 / 100
This Just In Radio: AI in Action with Tony Nunes of AMDThis Just In Radio Show · on Drug Discovery64 / 100
Dr. Kristen Gilliland: A Mother's Journey from Neuroscience to AdvocacyHeart of the Matter · on neuroscience64 / 100
Decoding AQ with Ross Thornley Feat. Lisa Hammond - Chief Human Resources Officer at VeradigmDECODING AQ · on Drug Discovery64 / 100
AI and The Future Of Behavioral Health w/ Alon Joffe, Co-Founder & CEO, Eleos Health88 / 100
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio Therapeutics94 / 100
Preparing for the Pandemic We Haven't Seen Yet w/ Dr. Dan Barouch & Kris Brown, Vector Sciences87 / 100Mark Cuban on Why Patients Don’t Trust Their Medical Bills85 / 100
Why Healthcare Prices Are Like Fight Club w/ Mark Cuban, Co-Founder, Cost Plus Drugs100 / 100